Following the review of around 20 candidate vaccines by the external advisory group, MVC's vaccine was selected as one of two to be included in the global trial
Filing marks first protein-based vaccine submitted to MHRA for authorization
Support from DFC will help produce one billion vaccine doses by the end of 2022
The list of kids with co-morbidities eligible for vaccination would be announced by the government
The interim analysis showed that the MVC-COV1901 vaccine has a good safety profile and elicits promising neutralising antibody titres
The first study to investigate the safety and immunogenicity of both vaccines when co-administered compared to each vaccine administered separately in adults aged 65 years and older
It recommends using the vaccine to prevent the spread of the disease
This is the first time in South Asia an indigenously made drone was used to transport Covid-19 vaccines
India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys
It is a recombinant nanoparticle protein-based vaccine
Subscribe To Our Newsletter & Stay Updated
